C.M. Bidwell & Associates’s Encompass Health EHC Stock Holding History

C.M. Bidwell & Associates’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$54.7K	Sell	566 -183	-24%	-$18.8K	0.03%	218
2025 Q4	$79.5K	Sell	749 -1,349	-64%	-$156K	0.04%	203
2025 Q3	$266K	Buy	2,098 +277	+15%	+$33K	0.13%	102
2025 Q2	$223K	Buy	1,821 +1,086	+148%	+$124K	0.12%	121
2025 Q1	$74.4K	Sell	735 -15	-2%	-$1.47K	0.04%	183
2024 Q4	$69.3K	Buy	750 +318	+74%	+$31.2K	0.04%	209
2024 Q3	$41.7K	Sell	432 -83	-16%	-$7.46K	0.03%	233
2024 Q2	$44.2K	Hold	515	–	–	0.03%	232
2024 Q1	$42.5K	Hold	515	–	–	0.03%	232
2023 Q4	$34.4K	Hold	515	–	–	0.03%	249
2023 Q3	$34.6K	Buy	+515	New	+$35.4K	0.03%	312
2021 Q4	–	Sell	-2,828	Closed	-$169K	–	570
2021 Q3	$169K	Hold	2,828	–	–	0.11%	181
2021 Q2	$176K	Buy	+2,828	New	+$188K	0.12%	169

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

C.M. Bidwell & Associates's EHC Position: Q1 2026 in Review

C.M. Bidwell & Associates reduced its Encompass Health (EHC) stake by 24% in Q1 2026, selling an estimated $18.8K and leaving 566 shares worth $54.7K. The position accounts for 0.03% of the portfolio, ranked #218.

C.M. Bidwell & Associates first reported a position in EHC in Q2 2021 and has held it in 13 quarters since. The position peaked at $266K in Q3 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

C.M. Bidwell & Associates held 566 shares of Encompass Health worth $54.7K as of Q1 2026.
C.M. Bidwell & Associates sold 183 Encompass Health shares in Q1 2026, an estimated $18.8K.
Encompass Health made up 0.03% of C.M. Bidwell & Associates's portfolio in Q1 2026, its #218 holding.
C.M. Bidwell & Associates first reported a position in Encompass Health in Q2 2021 and has held it in 13 quarters since.
C.M. Bidwell & Associates's Encompass Health position peaked at $266K in Q3 2025.
577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.